Biological Information
Background Information:
IKKgamma is the regulatory subunit of the inhibitor of IkB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Binding of IKKgamma to IKKalpha and IKKbeta subunits activates the IKK complex which then phosphorylates the I?Balpha inhibitor protein, leading to its ubiquitin-dependent degradation via the 26S proteasome, and release of NF-kappaB dimers p105 and RELA to translocate to the nucleus and activate transcription of NF-kappaB responsive genes. Due to its central regulatory role in modulating NF-kappaB signalling, IKKgamma has become a focus of drug discovery efforts aimed at cancer and inflammatory diseases. For example, disruption of the IKKgamma-IKKbeta complex by peptides or small molecules has been shown to suppress NF-kappaB activity and impair tumour cell proliferation.
Target Class:
Ubiquitination-related
Family:
IKK
Sub Family:
Regulatory protein
Protein Name:
IKKgamma
Protein Aliases:
NEMO; FIP-3; FIP3; IKKAP1; IKKG; IKKg
Accession Number:
AF091453.1
UniProt Number:
Q9Y6K9
Gene Name:
IKBKG
Gene ID:
8517
Gene Aliases:
IP; IP1; IP2; FIP3; IKKG; IPD2; NEMO; FIP-3; Fip3p; IMD33; SAIDX; AMCBX1; EDAID1; IKKAP1; ZC2HC9; IK
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Enzymatic
Assay Measures:
ECL
Bioassay Data
Trademark Statement:
For Research Use Only
Clinical Relevance
Therapeutic Area:
Oncology/Inflammation